IL13 and prostate carcinoma: Co-cultivation of PC3 prostate cancer cells and primary human myoblasts yielded in higher IL-4 and IL-13 serum levels, which induced syncytin-1, annexin V, and CD133 expression in PC3 cancer cells that was further correlated with an enhanced fusion frequency [88].